NantHealth Announces New Expanded Coverage of GPS Cancer Test with Self-Insured Employers, ‎ Insurance Payers, and Health Systems

NantHealth, LLC, announced the expanded adoption of GPS Cancer, a unique comprehensive molecular test to help oncology care providers guide treatment strategies for cancer care, by partnering with major self-insurers that have agreed to cover the costs for their employees requiring this test. Bank of America, Phoenix Children’s Hospital, Sanford Health will become the first national and regional self-insured employers to cover next-generation whole genome sequencing and proteomics for various cancers.

Read full press release here.